Company Profile

Lifeblood Medical Inc
Profile last edited on: 1/26/2016      CAGE: 4KBS6      UEI: MEUQKF6AZKL1

Business Identifier: Oxygen and Nutrient-bearing Nanoparticle solution for preservation and repair of human cells, tissues and organs while awaiting or undergoing research, diagnostic, or therapeutic procedures
Year Founded
2004
First Award
2012
Latest Award
2012
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

958 Adelphia Road
Adelphia, NJ 07728
   (732) 431-5833
   info@lifebloodmedical.com
   www.lifebloodmedical.com
Location: Single
Congr. District: 04
County: Monmouth

Public Profile

Lifeblood Medical Inc is a biopharmaceutical company dedicated to the enhancement of organ preservation through room temperature preservation. Lifeblood’s technology, based on nano-carrier properties, is thus able to extend the length of time an organ can be preserved. This would be accomplished by focusing on what every cell needs to function, namely oxygen and nutrients. The firms nano-lipid technology, Lifor, is an animal component free preservation technology that contains cellular nutrients, non-protein oxygen and nanoparticle carriers. Lifor has the ability to carry oxygen and nutrients to cells and tissues, enabling them to sustain metabolic processes and keep the cells alive; a critical factor in organ transplantation.The technology has been proven to carry and release oxygen to the heart, kidney, severed limbs and body; all without excreting toxicity and potassium. It was soon discovered that the properties of the technology extended beyond just organ preservation, leading to the technology being used for various uses including: cryopreservation, culture cells without using Fetal Bovine Serum, room temperature shipping and storage of cells, limb preservation, human organ regeneration and oxygen therapeutics.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2012 1 Army $99,100
Project Title: Maintenance of Tissue Metabolism for at Least 3 Hours between 20-28oC with an Asanguinous Fluid

Key People / Management

  Joseph Fischer -- Chairman; President; Chief Executive Officer; Founder

  Donald Kender -- Quality & Regulatory Affairs Compliance Officer

  Charles Sininski -- Chief Financial Officer

Company News

There are no news available.